The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis
Abstract
The purpose of this study was to determine the cumulative incidence of lupus nephritis (LN) and the factors predictive of its occurrencein a multiethnic systemic lupus erythematosus (SLE) cohort. We studied 353 SLE patients as de” ned by the American College of Rheumatology (ACR) criteria (65 Hispanics, 93 African-Americans and 91 Caucasians). First, we determined the cumulative incidence of LN in all patients. Next, we determined the predictors for LN in those with nephritis occurring after diagnosis. The dependent variable, LN, was de” ned by: (1) A renal biopsy demonstrating World Health Organization (WHO), class II–V histopathology; and/or (2) proteinuria≥ 0.5 g=24 h or 3 + proteinuria attributable to SLE; and/or (3) one of the following features also attributable to SLE and present on two or more visits, which were performed at least 6 months apart— proteinuria≥ 2 +, serum creatinine≥ 1.4 mg/dl, creatinine clearance ≤ 79 ml/min, 10 RBCs or WBCs per high power ” eld (hpf), oŗ 3 granular or cellular casts per hpf. Independent variables assessed at diagnosis, and if absent, at baseline, were from four domains: sociodemographic, clinical, immunologic and immunogenetic (including the complete antibody pro” le and MHC class II alleles), and health habits. Variables with P < 0.05 by chi square analyses were entered into domain-speci”c stepwise logistic regression analyses controlling for disease duration, with LN as the dependent variable. Signi” cant domain-speci”c regression variables (P ≤ 0.1) were then entered into an overall model. The cumulative incidence of LN was 54.3% in all patients, and 35.3% for those developing LN after diagnosis. LN after diagnosis occurred in 43.1% of 65 Hispanics, 50.5% of 93 African-Americans, and 14.3% of 91 Caucasians, P < 0.0001. The duration of follow-up for those with LN after diagnosis was 5.5§ 2.4 vs 4.0§ 2.9 years for those without LN. Hispanic (odds ratio (OR) = 2.71, 95% con” dence limits (CL) = 1.07–6.87, P < 0.04) and African-American ethnicities (OR = 3.13, 95% CL = 1.21–8.09, P < 0.02), not married or living together (OR = 3.45, 95% CL = 1.69–7.69, P < 0.0003), higher SLAM score (OR = 1.11, 95% CL = 1.02–1.19, P < 0.007), anti-dsDNA (OR = 3.14, 95% CL = 1.50–6.57, P < 0.0001) and anti-RNP (OR = 4.24, CL = 1.98–9.07, P < 0.0001) antibodies were shown to be signi” cant predictors of the occurrence of LN. Repeated analyses excluding the patients with missing HLA data showed that absence of HLA-DQB1*0201 was also a signi” cant predictor for the occurrence of LN (OR = 2.34, CL = 1.13–5.26, P < 0.04). In conclusion, LN occurred signi” cantly more often in Hispanics and African-Americans with SLE. Sociodemographic,clinical and immunologic/immunogenetic factors seem to be predictive of LN occurring after the diagnosis of SLE has been made.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Gladman, D., Ginzler, E., Goldsmith, C., Fortin, P., Liang, M., Sanchez‐Guerrero, J., Urowitz, M., Bacon, P., Bombardieri, S., Hanly, J., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390303 · Cited by 2,582
Psychosocial Influences on Mortality after Myocardial Infarction
Ruberman, W., Weinblatt, E., Goldberg, J. D., & Chaudhary, B. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408303110902 · Cited by 975
THE NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSIS
ESTES, D., & CHRISTIAN, C. L. (1971) · Medicine · doi:10.1097/00005792-197103000-00001 · Cited by 936
Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.
Mohan, C., Adams, S., Stanik, V, & Datta, S. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1367 · Cited by 627
Ter Borg, E. J., Horst, G., Hummel, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330505 · Cited by 572
Aarden, L. A., Groot, E. R. D., & Feltkamp, T. E. W. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb29197.x · Cited by 563
Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans.
Salmon, J. E., Millard, S., Schachter, L. A., Arnett, F. C., Ginzler, E. M., Gourley, M. F., Ramsey-Goldman, R., Peterson, M. G., & Kimberly, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118552 · Cited by 469
Winfield, J. B., Faiferman, I., & Koffler, D. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108626 · Cited by 405
Lupus erythematosus in the 1980s: A survey of 570 patients
Pistiner, M., Wallace, D. J., Nessim, S., Metzger, A. L., & Klinenberg, J. R. (1991) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(91)90057-7 · Cited by 403
A multicenter study of outcome in systemic lupus erythematosus.
Ginzler, E. M., Diamond, H. S., Weiner, M., Schlesinger, M., Fries, J. F., Wasner, C., Medsger, T. A., Ziegler, G., Klippel, J. H., Hadler, N. M., et al. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250601 · Cited by 388
Prognosis in systemic lupus erythematosus
Reveille, J. D., Bartolucci, A., & Alarcón, G. S. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330105 · Cited by 330
Self-citationAlarc�n, G. S., McGwin, Jr., Bastian, H. M., Roseman, J., Lisse, J., Fessler, B. J., Friedman, A. W., Reveille, J. D., & LUMINA Study Group (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200104)45:2<191::aid-anr173>3.0.co;2-2 · Cited by 325
Self-citationAlarcón, G. S., Friedman, A. W., Straaton, K. V., Moulds, J. M., Lisse, J., Bastian, H. M., McGwin, G., Bartolucci, A. A., Roseman, J. M., & Reveille, J. D. (1999) · Lupus · doi:10.1191/096120399678847704 · Cited by 309
Self-citationPrevention of relapses in systemic lupus erythematosus
Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., Wolters-Dicke, J., Gmelig-Meyling, F., Kater, L., & Hermans, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90114-0 · Cited by 290
Anti‐dsdna and complement profiles as prognostic guides in systemic lupus erythematosus
Swaak, A. J. G., Aarden, L. A., Statius Eps, L. W. V., & Feltkamp, T. E. W. (1979) · Arthritis & Rheumatism · doi:10.1002/art.1780220304 · Cited by 284
Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status
Petri, M., Perez-Gutthann, S., Longenecker, J. C., & Hochberg, M. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90151-m · Cited by 278
Reveille, J. D., Fischbach, M., McNearney, T., Friedman, A. W., Aguilar, M. B., Lisse, J., Fritzler, M. J., Ahn, C., & Arnett, F. C. (2001) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2001.20268 · Cited by 277
Self-citationAmoura, Z., Chabre, H., Koutouzov, S., Lotton, C., Cabrespines, A., Bach, J., & Jacob, L. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371118 · Cited by 208
Gladman, D. D., Goldsmith, C. H., Urowitz, M. B., Bacon, P. A., Bombardier, C., Isenberg, D. A., KALUNIAN, K. C., Liang, M. H., Maddison, P., & Nived, O. (1994) · PubMed · Cited by 202
Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking
Ward, M. M. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.10.2082 · Cited by 184
Tan, E. M., Smolen, J. S., McDougal, J. S., Butcher, B. T., Conn, D. L., Dawkins, R. L., Fritzler, M. J., Gordon, T., Hardin, J., Kalden, J. R., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:3<455::aid-anr10>3.0.co;2-3 · Cited by 175
Survival in systemic lupus erythematosus. a multivariate analysis of demographic factors
Studenski, S., Caldwell, D. S., Allen, N. B., Rice, J. R., & Polisson, R. P. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301202 · Cited by 163
Clinical Prognostic Factors in Lupus Nephritis
Ward, M. M. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400220098017 · Cited by 130
A Hexagonal (II) Phase Phospholipid Neutralization Assay for Lupus Anticoagulant Identification
Triplett, D. A., Barna, L. K., & Unger, G. A. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649671 · Cited by 129
Petri, M. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70135-6 · Cited by 121
The Time‐Dependence of Long‐Term Prediction in Lupus Nephritis
Esdaile, J. M., Abrahamowicz, M., MacKenzie, T. A., Hayslett, J. P., & Kashgarian, M. J. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370309 · Cited by 91
Gulko, P. S., Reveille, J. D., Koopman, W. J., Burgard, S. L., Bartolucci, A., & Alarcón, G. S. (1993) · PubMed · Cited by 68
Self-citationHopkinson, N., Jenkinson, C., Muir, K. R., Doherty, M., & Powell, R. J. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.2.116 · Cited by 65
Brekke, M., Hjortdahl, P., Thelle, D. S., & Kvien, T. K. (1999) · Social Science & Medicine · doi:10.1016/s0277-9536(99)00075-1 · Cited by 61
The longterm prognosis of lupus nephritis: the impact of disease activity.
Goulet, J. R., MacKenzie, T. A., Levinton, C. M., Hayslett, J. P., Ciampi, A., & Esdaile, J. M. (1993) · PubMed · Cited by 51
Environmental factors predicting nephritis in systemic lupus erythematosus.
McAlindon, T. E., Giannotta, L., Taub, N. A., D’Cruz, D. P., & Hughes, G. R. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.10.720 · Cited by 45
Circulating anti-DNA immune complexes in active lupus nephritis
Sasaki, T., Muryoi, T., Hatakeyama, A., Suzuki, M., Satō, H., Seino, J., Saito, T., & YOSHINAGA, K. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90152-n · Cited by 36
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Mortality in systemic lupus erythematosus
Bernatsky, S., Boivin, J. ‐., Joseph, L., Manzi, S., Ginzler, E., Gladman, D. D., Urowitz, M., Fortin, P. R., Petri, M., Barr, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21955 · Cited by 1,181
Self-citationAnders, H.-J., Saxena, R., Zhao, M.-H., Parodis, I., Salmon, J. E., & Mohan, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0141-9 · Cited by 958
Almaani, S., Meara, A., & Rovin, B. H. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05780616 · Cited by 930
Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus
Pons-Estel, G. J., Alarcón, G. S., Scofield, L., Reinlib, L., & Cooper, G. S. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.10.007 · Cited by 908
Self-citation
Metadata
- Authors
- Bastian, H. M., Roseman, J. M., Mcgwin, G., Alarcón, G. S., Friedman, A. W., Fessler, B. J., Baethge, B. A., Reveille, J. D., & Lumina Study Group
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 2002-03
- Volume
- 11
- Issue
- 3
- Pages
- 152-160
- ISSN
- 0961-2033 (ISSN-L)
- 1477-0962
- OpenAlex
- W2158300364
- Cited by
- 360
- References
- 33
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.